Skip to main content
Log in

Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

An important parameter in the development of pharmacokinetic models is the ratio of tissue drug concentration to the concentration of the drug in the arterial plasma or the effluent plasma. The relationship between these two tissue/plasma ratios is derived analytically for different routes of drug administration. The two are equal only in compartments with no elimination when the drug is infused at constant rate. For other routes of administration, the two ratios are identical in all compartments only when there is no elimination process. The tissue/plasma concentration ratios for infusion equilibrium are not equal to the corresponding values for the postdistribution phase after an intravenous bolus injection. When the plasma concentration for infusion and injection are the same, more drug will appear in the lung during infusion steady state than during the postdistribution equilibrium. The reverse is true for the other organs. The importance of properly defining the tissue/plasma ratio and its implication for pharmacokinetic modeling are discussed. The results may have important therapeutic implications for the availability of drugs using different routes of administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Drug. Symp. Ser. 62(66):32–45 (1966).

    Google Scholar 

  2. K. B. Bischoff. Applications of a mathematical model for drug distribution in mammals. In D. Hershey (ed.),Chemical Engineering in Medicine and Biology, Plenum, New York, 1967, pp. 417–446.

    Chapter  Google Scholar 

  3. K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57:1346–1351 (1968).

    Article  CAS  PubMed  Google Scholar 

  4. K. B. Bischoff, R. L. Dedrick, and D. S. Zaharko. Preliminary model for methotrexate pharmacokinetics.J. Pharm. Sci. 59:149–154 (1970).

    Article  CAS  PubMed  Google Scholar 

  5. K. B. Bischoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).

    Article  CAS  PubMed  Google Scholar 

  6. R. L. Dedrick, D. D. Forrester, and D. H. W. Ho. In-vitro-In-vivo correlation of drug metabolism-Determination of 1-Β-D-arabinsfurenosylcytosine.Biochem. Pharmacol. 21:1–16 (1972).

    Article  CAS  PubMed  Google Scholar 

  7. N. Benowitz, R. P. Forsyth, K. L. Melman, and M. Rowland. Lidocaine disposition kinetics in monkey and man. I. Predicted by a perfusion model.Clin. Pharmacol. Ther. 16:87–98 (1974).

    CAS  PubMed  Google Scholar 

  8. N. Benowitz, R. P. Forsyth, K. L. Melman, and M. Rowland. Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration.Clin. Pharmacol. Ther. 16:99–109 (1974).

    CAS  PubMed  Google Scholar 

  9. B. Montandon, R. J. Roberts, and L. J. Fisher. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.J. Pharmacokin. Biopharm. 3:277–290 (1975).

    Article  CAS  Google Scholar 

  10. P. A. Harris and J. F. Gross. Preliminary pharmacokinetics model for adriamycin (NSC-123127).Cancer Chemother. Rep. Part I 59:819–825 (1975).

    CAS  Google Scholar 

  11. L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.J. Pharm. Sci. 66:1138–1142 (1977).

    Article  CAS  PubMed  Google Scholar 

  12. L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution in dogs and its preliminary application to humans.J. Pharm. Sci. 66:1679–1683 (1977).

    Article  CAS  PubMed  Google Scholar 

  13. K. J. Himmelstein and J. F. Gross. Mathematical model for cyclocytidine pharmacokinetics.J. Pharm. Sci. 66:1441–1444 (1977).

    Article  CAS  PubMed  Google Scholar 

  14. C. N. Chen, D. L. Coleman, J. D. Andrade, and A. R. Temple. Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs and tissues.J. Pharm. Sci. 67:38–45 (1978).

    Article  CAS  PubMed  Google Scholar 

  15. R. L. Dedrick. Animal scale-up.J. Pharmacokin. Biopharm. 1:435–461 (1978).

    Article  Google Scholar 

  16. K. Uchida and W. Kreis. Studies on drug resistance. I. Distribution of 1-Β-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing Ara-C-sensitive and -resistant P815 neoplasms.Biochem. Pharmacol. 18:1115–1128 (1969).

    Article  CAS  PubMed  Google Scholar 

  17. G. L. Neil, T. E. Moxley, and R. C. Manak. Enhancement by tetrahydrouridine of 1-Β-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.Cancer Res. 30:2166–2172 (1970).

    CAS  PubMed  Google Scholar 

  18. M. Gibaldi. Effect of mode of administration on drug distribution in a two-compartment open system.J. Pharm. Sci. 58:327–331 (1969).

    Article  CAS  PubMed  Google Scholar 

  19. R. J. Lutz, W. M. Galbraith, R. L. Dedrick, R. Shrager, and L. B. Mellett. A model for the kinetics of distribution of actinomycin-D in the beagle dog.J. Pharmacol. Exp. Ther. 200:469–478 (1977).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by Grant CA-17094 from the National Cancer Institute.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, H.S.G., Gross, J.F. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics 7, 117–125 (1979). https://doi.org/10.1007/BF01059446

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059446

Key words

Navigation